AD-65-WK61_0.01uM Gene Set

Dataset NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles
Category transcriptomics
Type drug perturbation
Description Dose=0.01uM, 3-{2-Cyano-2-[2-(2,4-difluoro-benzoylamino)-3-m-tolyl-propionylamino]-ethoxymethyl}-benzoic acid, Cathepsin B Inhibitors targeting CTSV, CTSL3P (Novartis, 10436731)
External Link https://pubchem.ncbi.nlm.nih.gov/compound/10436731
Similar Terms
Downloads & Tools

Genes

9 genes differentially expressed following the AD-65-WK61_0.01uM drug perturbation from the NIBR DRUG-seq U2OS MoA Box dataset.

increased expression

Symbol Name Standardized Value
GLS2 glutaminase 2 (liver, mitochondrial) 0.290049
DEUP1 deuterosome assembly protein 1 0.246664

decreased expression

Symbol Name Standardized Value
XPC xeroderma pigmentosum, complementation group C -0.493498
PRIM2 primase, DNA, polypeptide 2 (58kDa) -0.290049
AGBL5 ATP/GTP binding protein-like 5 -0.253643
RPL3 ribosomal protein L3 -0.251464
CNTROB centrobin, centrosomal BRCA2 interacting protein -0.228822
HBP1 HMG-box transcription factor 1 -0.200085
ARIH2 ariadne RBR E3 ubiquitin protein ligase 2 -0.200085